Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Duke Rohlen
AddedMar 31, 2024
UpdatedJun 28, 2026
Duke Rohlen

Duke Rohlen

Board Member, Zeus Health

CrunchbaseLinkedIn

Duke Rohlen's Career

Zeus Health
Zeus Health

Menlo Park, CA, US

Board Member· Board
Verix Health
Verix Health

Philadelphia, PA, US

Board Member· Board
Atriomx
Atriomx

Menlo Park, CA, US

CEO· C-Suite · Management
Ablacon
Ablacon

Wheat Ridge, CO, US

Board Member· Board
Ajax Health
Ajax Health

Menlo Park, CA, US

Founder & CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Duke Rohlen's Career

Zeus Health
Zeus Health
6Menlo Park, CA, US
Board Member· Board

Leadership at Zeus Health

Philip WicklinePhilip WicklineCo-Founder

Similar to Zeus Health

BrainHealthBrainHealthDunedin, FL, USMedical Equipmentest. 2015BrainHealthDunedin, FL, US · est. 2015

BrainHealth: Innovating and supplying advanced neurological medical equipment.

Series C · $465M75
Piraeus MedicalPiraeus MedicalRochester, MN, USMedical Devicesest. 2021Piraeus MedicalRochester, MN, US · est. 2021

Piraeus Medical: A stealth-mode healthcare company creating devices for enhanced patient care.

Seed · $3.1k6
Zenith Technical InnovationsZenith Technical InnovationsGurnee, IL, USMedical Devicesest. 2014Zenith Technical InnovationsGurnee, IL, US · est. 2014

Zenith Technical Innovations: Illinois-based medical device manufacturer and distributor, specializing in versatile therapy solutions.

Seed · $3.1M3
Sequoia Health StrategiesSequoia Health StrategiesNew York City, NY, USMedical ServicesSequoia Health StrategiesNew York City, NY, US

NYC-based medical organization, Sequoia Health Strategies.

50
Verix Health
Verix Health
Series A$8.2M302016Philadelphia, PA, US
Board Member· Board
Atriomx
Atriomx
Pre-Seed$11M62020Menlo Park, CA, US
CEO· C-Suite · Management

Similar to Atriomx

Atrility MedicalAtrility MedicalMadison, WI, USMedical Devicesest. 2017Atrility MedicalMadison, WI, US · est. 2017

Cardiac device manufacturer setting new standards in arrhythmia monitoring with AtriAmp.

Series A · $4M9
InnerpulseInnerpulseTriangle (historical), NC, USMedical Devicesest. 2003InnerpulseTriangle (historical), NC, US · est. 2003

InnerPulse, Inc.: Innovating cardiac arrhythmia treatment through advanced technology and devices.

Series D · $50M8
CoreMapCoreMapBurlington, VT, USMedical Devicesest. 2016CoreMapBurlington, VT, US · est. 2016

CoreMap: Enhancing patient outcomes with advanced diagnostic technology for electrophysiologists.

Series A · $33.8M35
CardioPhiCardioPhiMilpitas, CA, USSoftwareCardioPhiMilpitas, CA, US

California-based CardioPhi develops software to enhance cardiac arrhythmia outcomes, reducing healthcare costs.

Angel · $256k5
Ablacon
Ablacon
Series B$63.5M292015Wheat Ridge, CO, US
Board Member· Board

Leadership at Ablacon

Peter RuppersbergPeter RuppersbergFounder
Ajax Health
Ajax Health
Series C$315M312017Menlo Park, CA, US
Founder & CEO· C-Suite · Management

Leadership at Ajax Health

Aftab KheraniAftab KheraniBoard Member
Garheng KongGarheng KongBoard Member

Duke Rohlen's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Duke Rohlen

Nathaniel Justin KanNathaniel Justin KanBoard Member · ZerocaterMike CarrelMike CarrelBoard Member · AxonicsJeff McLarenJeff McLarenBoard Member · HealthStreamPaul RhodesPaul RhodesCo-Founder & CEO · MetabolomxDavid A. BattatDavid A. BattatCEO · AtrionGreg GalvinGreg GalvinCEO · Mezmeriz